Unichem Laboratories Statistics
Total Valuation
NSE:UNICHEMLAB has a market cap or net worth of INR 26.34 billion. The enterprise value is 29.42 billion.
| Market Cap | 26.34B |
| Enterprise Value | 29.42B |
Important Dates
The last earnings date was Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 70.41M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 20.06M |
Valuation Ratios
The trailing PE ratio is 8.93.
| PE Ratio | 8.93 |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.98 |
| EV / Sales | 1.33 |
| EV / EBITDA | 13.53 |
| EV / EBIT | 31.66 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 2.31 |
| Debt / FCF | n/a |
| Interest Coverage | 3.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.02% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 2.60% |
| Revenue Per Employee | 7.05M |
| Profits Per Employee | 938,574 |
| Employee Count | 3,142 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:UNICHEMLAB has paid 364.90 million in taxes.
| Income Tax | 364.90M |
| Effective Tax Rate | 11.01% |
Stock Price Statistics
The stock price has decreased by -44.40% in the last 52 weeks. The beta is -0.38, so NSE:UNICHEMLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.38 |
| 52-Week Price Change | -44.40% |
| 50-Day Moving Average | 414.52 |
| 200-Day Moving Average | 505.08 |
| Relative Strength Index (RSI) | 39.80 |
| Average Volume (20 Days) | 35,441 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:UNICHEMLAB had revenue of INR 22.14 billion and earned 2.95 billion in profits. Earnings per share was 41.79.
| Revenue | 22.14B |
| Gross Profit | 11.39B |
| Operating Income | 929.50M |
| Pretax Income | 3.31B |
| Net Income | 2.95B |
| EBITDA | 2.10B |
| EBIT | 929.50M |
| Earnings Per Share (EPS) | 41.79 |
Balance Sheet
The company has 1.93 billion in cash and 5.02 billion in debt, with a net cash position of -3.08 billion.
| Cash & Cash Equivalents | 1.93B |
| Total Debt | 5.02B |
| Net Cash | -3.08B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 24.35B |
| Book Value Per Share | 346.08 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 51.43%, with operating and profit margins of 4.20% and 13.32%.
| Gross Margin | 51.43% |
| Operating Margin | 4.20% |
| Pretax Margin | 14.97% |
| Profit Margin | 13.32% |
| EBITDA Margin | 9.50% |
| EBIT Margin | 4.20% |
| FCF Margin | n/a |
Dividends & Yields
NSE:UNICHEMLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.28% |
| Shareholder Yield | -0.28% |
| Earnings Yield | 11.20% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 21, 2010. It was a forward split with a ratio of 2.5.
| Last Split Date | Oct 21, 2010 |
| Split Type | Forward |
| Split Ratio | 2.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |